GleamWall
中文EN

PURE PURE BIOSCIENCE, INC.

Miscellaneous Chemical Products · OTC · SEC CIK 1006028 · Fiscal year ends 07/31

Financial factors as of 2026-07-31 (2026Q4), TTM = sum of the last four quarters

Growth

TTM revenue YoY5.3%
TTM net income YoY-3.5%
TTM EPS YoY0.0%
Revenue 3-yr CAGR7.4%
Net income 3-yr CAGR—

Margins

Gross margin57.3%
Operating margin-90.0%
Net margin-107.3%
FCF margin—
EBITDA margin-89.8%

Returns

ROE—
ROA-220.6%
ROIC (approx.)—
Asset turnover2.06x

Leverage & solvency

Liabilities / assets636.4%
Debt / equity—
Current ratio0.27x
Interest coverage-5.12x

Cash quality & payout

Operating cash flow / net income0.70x
Accruals ratio-66.2%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q4*2026-07-312026Q32026-04-302026Q22026-01-312026Q12025-10-312025Q4*2025-07-312025Q32025-04-302025Q22025-01-312025Q12024-10-31
Income statement
Revenue$659,000$506,000$443,000$707,000$763,000$489,000$391,000$555,000
Cost of revenue$291,000$237,000$206,000$258,000$296,000$208,000$164,000$231,000
Gross profit$369,000$269,000$238,000$450,000$468,000$283,000$227,000$325,000
R&D expense$93,000$79,000$74,000$86,000$73,000$91,000$81,000$71,000
SG&A expense$779,000$708,000$847,000$743,000$731,000$776,000$871,000$881,000
Operating income-$503,000-$518,000-$683,000-$379,000-$336,000-$584,000-$725,000-$627,000
Interest expense$106,000$106,000$101,000$94,000$89,000$78,000$70,000$62,000
Net income-$610,000-$624,000-$785,000-$464,000-$332,000-$580,000-$798,000-$689,000
EBITDA-$502,000-$518,000-$682,000-$378,000-$336,000-$583,000——
EPS (basic)—-0.01-0.010.00—-0.01-0.01-0.01
EPS (diluted)—-0.01-0.010.00—-0.01-0.01-0.01
Weighted avg. shares (diluted)—110.83M111.89M111.89M—111.86M111.86M111.86M
Balance sheet
Cash & equivalents$569,000$983,000$198,000$434,000$334,000$540,000$202,000$346,000
Receivables$334,000$242,000$252,000$389,000$474,000$287,000$180,000$371,000
Inventory$193,000$232,000$244,000$237,000$141,000$131,000$75,000$72,000
Current assets$1.19M$1.55M$779,000$1.18M$1.05M$1.05M$562,000$911,000
PP&E, net$8,000$9,000$9,000$10,000$11,000$11,000$12,000$13,000
Total assets$1.19M$1.56M$788,000$1.19M$1.06M$1.06M$574,000$924,000
Current liabilities$4.37M$3.65M$3.06M$3.16M$2.11M$972,000$866,000$911,000
Long-term debt$6.60M———————
Total debt$6.60M———————
Total liabilities$7.59M$7.40M$7.06M$6.73M$6.17M$5.87M$4.84M$4.42M
Shareholders' equity-$6.40M-$5.84M-$6.27M-$5.55M-$5.12M-$4.81M-$4.27M-$3.50M
Net debt$6.03M———————
Shares outstanding130.02M130.02M111.89M111.89M111.89M111.86M111.86M111.86M
Cash flow statement
Operating cash flow-$414,000-$468,000-$606,000-$250,000-$456,000-$512,000-$544,000-$503,000
Financing cash flow$0$1.25M$370,000$350,000$250,000$850,000$400,000$500,000
Depreciation & amortization$1,000$0$1,000$1,000$0$1,000——
Stock-based compensation$50,000$55,000$58,000$34,000$30,000$33,000$27,000$57,000

Free plan shows the latest 8 periods; Pro shows all 64 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.